DE

Oncology

You’re pushing hard for breakthroughs in oncology. We’re here to help.

In the constantly evolving field of developing oncological therapies we support our clients with our well trained and experienced team that has completed numerous clinical trials spanning a broad variety of indications with an excellent site relationship and knowledge of successful strategies even in most novel therapy fields.
 

Our core competencies in the field of solid tumor cancers and hematological disorders:

  • Plan and manage effective complex studies
  • Expedite patient recruitment
  • Develop strategies for a competitive enrollment in phase I trials
  • Resolve site specific and country specific issues
  • Execution of studies in all phases

We have performed international first-in-man and first-in-patient studies.
 

Therapeutic approaches include but are not limited to:

  • Personalized therapy
  • Immunomodulator vaccines
  • Devices
  • Cytotoxic agents
  • Gene therapy
  • Small molecules
  • Antiangiogenics
  • Monocolonal antibodies
  • Hormonal therapy
  • Antisense agents
  • Antibody mimetic proteins
  • Photodynamic therapy


If you’re interested in our broad experience across managing the complexity of modern trial design, get in touch with us.

  • Prof. Michael Hudecek

    Chair of Cellular Immunotherapy from University Hospital Wuerzburg

    "Since 2018, FGK has been an invaluable partner in our clinical early-phase CAR-T cell projects. Their extensive experience in advanced new therapies, like ATMP and cell therapy projects, has provided us with the expertise and support needed to navigate this complex field. Their commitment to high-quality research and their deep understanding of innovative therapies make them a trusted and essential partner in our development efforts. We look forward to continuing this successful collaboration."